Edgewise Therapeutics, Inc. EWTX
$33.94
▲ +2.65% 24H
About
Edgewise Therapeutics Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative therapies targeting rare muscle disorders. The company's primary function is to address unmet medical needs in the area of muscular health, specifically aiming to develop treatments …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees154
TickerEWTX
Statistics
Market Cap$3.65B
Revenue (TTM)$0
Net Income-$167.8M
Net Margin—
EPS$-1.63
P/E-20.82
P/S—
P/B7.23
EV/EBITDA-16.05
ROE-38.1%
Dividend Yield—
Price$33.94
Data: Twelve Data · Revenue = mcap / P/S